Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT)
1 ESGT Central Office Institutür Experimentelle Onkologie und Therapieforschung Technische Universität München Ismaninger Str. 22 81675 Munich, Germany.